Krishnaveni K, Roy P, Sambathkumar R. Knowledge, attitude and practice related to cervical cancer and screening among women: community based cross-sectional study. Int J Pharm Sci Res. 2018;9(2):722–9.
Mofolo N, Sello M, Leselo M, Chabanku N, Naidoo Q, Joubert G. Knowledge of cervical cancer, human papillomavirus and prevention among first-year female students in residences at the University of the Free State. Afr J Primary Health Care Fam Med. 2018;10(1):1–5.
Pegu B, Dhiman N, Chaturvedi J, Sharma SK. Nurse’s knowledge and attitude regarding cervical cancer screening at a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2017;6:907–10.
Aswathy S, Quereshi MA, Kurian B, Leelamoni K. Cervical cancer screening: current knowledge & practice among women in a rural population of Kerala, India. Indian J Med Res. 2012;136(2):205.
Momenimovahed Z, Salehiniya H. Incidence, mortality and risk factors of cervical cancer in the world. Biomed Res Ther. 2017;4(12):1795–811.
Adejuyigbe FF, Balogun BR, Sekoni AO, Adegbola AA. Cervical cancer and human papilloma virus knowledge and acceptance of vaccination among medical students in Southwest Nigeria. Afr J Reprod Health. 2015;19(1):140–8.
Ofori P, Ebu NI, John ME, Siakwa MP. Knowledge, attitude and practice of cervical cancer screening among female students of University of Cape Coast Ghana. Ghana: University of Cape Coast; 2014.
Marek E, Dergez T, Rebek-Nagy G, Szilard I, Kiss I, Ember I, Gocze P, D’Cruz G. Effect of an educational intervention on Hungarian adolescents’ awareness, beliefs and attitudes on the prevention of cervical cancer. Vaccine. 2012;30(48):6824–32.
Denny L. Cervical cancer: prevention and treatment. Discov Med. 2012;14(75):125–31.
Waiswa A, Nsubuga R, Muwasi M, Kimera I, Ndikabona G, Tusingwire PD, Mshilla M, Ovuga E, Akera P. Knowledge and attitude towards cervical cancer screening among females attending out patient department in health Centre IIIs in Oyam District. Open J Prev Med. 2017;7(04):55.
Louie KS, De Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health. 2009;14(10):1287–302.
Irabor GI, Akpan D, Aigbe E, Omoruyi KA, Amaechi U, Omotoso AJ, Nnoli MA. Specific human papillomavirus genotypes isolated from cervical cancer specimens in Calabar, Nigeria. J Cancer Tumor Int. 2018;5:1–1.
Ozyer S, Uzunlar O, Ozler S, Kaymak O, Baser E, Gungor T, Mollamahmutoglu L. Awareness of Turkish female adolescents and young women about HPV and their attitudes towards HPV vaccination. Asian Pac J Cancer Prev. 2013;14(8):4877–81.
Awua AK, Sackey ST, Osei YD, Asmah RH, Wiredu EK. Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana. Infect Agents Cancer. 2016;11(1):1–9.
Nartey Y, Hill PC, Amo-Antwi K, Nyarko KM, Yarney J, Cox B. Factors contributing to the low survival among women with a diagnosis of invasive cervical cancer in Ghana. Int J Gynecol Cancer. 2017 1;27(9).
Binka C, Doku DT, Awusabo-Asare K. Experiences of cervical cancer patients in rural Ghana: an exploratory study. PLoS ONE. 2017;12(10):e0185829.
Laryea DO, Awuah B, Amoako YA, Osei-Bonsu E, Dogbe J, Larsen-Reindorf R, Ansong D, Yeboah-Awudzi K, Oppong JK, Konney TO, Boadu KO. Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry. BMC Cancer. 2014;14(1):1–8.
Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjosé S, Castellsagué X. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4(7):e453–63.
Der EM, Adu-Bonsaffoh K, Tettey Y, Kwame-Aryee RA, Seffah JD, Alidu H, Gyasi RK. Clinico-pathological characteristics of cervical cancer in Ghanaian women. J Med Biomed Sci. 2014;3(3):27–32.
Asante KS, Mohammed AG, Delle AA, Mumuni AN. Cervical cancer knowledge and screening among schooling and uneducated females within Tamale-Ghana. J Adv Med Med Res. 2019;14:1–5.
William M, Kuffour G, Ekuadzi E, Yeboah M, ElDuah M, Tuffour P. Assessment of psychological barriers to cervical cancer screening among women in Kumasi, Ghana using a mixed methods approach. Afr Health Sci. 2013;13(4):1054–61.
Rerucha CM, Caro RJ, Wheeler V. Cervical cancer screening. Am Fam Phys. 2018;97(7):441–8.
Wright TC Jr, Kuhn L. Alternative approaches to cervical cancer screening for developing countries. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):197–208.
Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, Goldie SJ, Harper DM, Kinney W, Moscicki AB, Noller KL. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA. 2007;57(1):7–28.
Blumenthal PD, Gaffikin L, Deganus S, Lewis R, Emerson M, Adadevoh S, Group GC. Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol. 2007;196(4):407-e1.
Williams MS, Kenu E, Dzubey I, Dennis-Antwi JA, Fontaine K. A qualitative study of cervical cancer and cervical cancer screening awareness among nurses in Ghana. Health Care Women Int. 2018;39(5):584–94.
Coleman MA, Levison J, Sangi-Haghpeykar H. HPV vaccine acceptability in Ghana. West Afr Vac. 2011;29(23):3945–50.
Binka C, Nyarko SH, Doku DT. Cervical cancer knowledge, perceptions and screening behaviour among female university students in Ghana. J Cancer Educ. 2016;31(2):322–7.
Annan FM, Asante KO, Kugbey N. Perceived seriousness mediates the influence of cervical cancer knowledge on screening practices among female university students in Ghana. BMC Womens Health. 2019;19(1):1–8.
Maxwell JA. Qualitative research design: an interactive approach. Thousand Oaks: Sage Publications; 2012.
Berkwits M. From practice to research: the case for criticism in an age of evidence. Soc Sci Med. 1998;47(10):1539–45.
Litosseliti L. Using focus groups in research. London: A&C Black; 2003.
Bazeley P. Analysing mixed methods data. Mixed methods research for nursing and the health sciences. 2009;2:84–118
Namanji S, Ssekyewa C. Role and nature of research in development. Makerere J High Educ. 2012;4(1):83–92.
Bittlinger M. The patient’s voice in DBS research: advancing the discussion through methodological rigor. AJOB Neurosci. 2017;8(2):118–20.
Aniebue PN, Aniebue UU. Awareness and practice of cervical cancer screening among female undergraduate students in a Nigerian university. J Cancer Educ. 2010;25(1):106–8.
Francis SA, Battle-Fisher M, Liverpool J, Hipple L, Mosavel M, Soogun S, Mofammere N. A qualitative analysis of South African women’s knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine. 2011;29(47):8760–5.
Ferrer HB, Trotter C, Hickman M, Audrey S. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health. 2014;14(1):1–22.
Ihudiebube S, Ndidiamaka C, Jisieike O, Nonyelum N, Ezeh EN, Odikpo LC, Umezinwa CJ, Mba FC. Attitude and perceived barriers to uptake of human papillomavirus vaccine among female students in a nigerian tertiary institution. Int J Med Res Health Sci. 2019;8(4):85–92.
Kotaniemi-Talonen L, Nieminen P, Anttila A, Hakama M. Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br J Cancer. 2005;93(8):862–7.